Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma

Feder, Susanne and Kandulski, Arne and Schacherer, Doris and Weiss, Thomas S. and Buechler, Christa (2019) Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20 (16): 3919. ISSN 1661-6596, 1422-0067

Full text not available from this repository. (Request a copy)

Abstract

The chemoattractant adipokine chemerin is related to the metabolic syndrome, which is a risk factor for different cancers. Recent studies provide evidence that chemerin is an important molecule in colorectal cancer (CRC) and hepatocellular carcinoma (HCC). Serum chemerin is high in CRC patients and low in HCC patients and may serve as a differential diagnostic marker for HCC and liver metastases from CRC. To this end, serum chemerin was measured in 36 patients with CRC metastases, 32 patients with HCC and 49 non-tumor patients by ELISA. Chemerin serum protein levels were, however, similar in the three cohorts. Serum chemerin was higher in hypertensive than normotensive tumor patients but not controls. Cancer patients with hypercholesterolemia or hyperuricemia also had increased serum chemerin. When patients with these comorbidities were excluded from the calculation, chemerin was higher in CRC than HCC patients but did not differ from controls. Chemerin did not correlate with the tumor markers carcinoembryonic antigen, carbohydrate antigen 19-9 and alpha-fetoprotein in both cohorts and was not changed with tumor-node-metastasis stage in HCC. Chemerin was not associated with hepatic fat, liver inflammation and fibrosis. To conclude, systemic chemerin did not discriminate between CRC metastases and HCC. Comorbidities among tumor patients were linked with elevated systemic chemerin.

Item Type: Article
Uncontrolled Keywords: MORBIDLY OBESE-PATIENTS; FATTY LIVER; MESSENGER-RNA; INFLAMMATION; EXPRESSION; VASPIN; ACTIVATION; CANCER; alpha-fetoprotein; liver steatosis; hypertension
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin I
Medicine > Lehrstuhl für Kinder- und Jugendmedizin
Depositing User: Dr. Gernot Deinzer
Date Deposited: 01 Apr 2020 06:20
Last Modified: 01 Apr 2020 06:20
URI: https://pred.uni-regensburg.de/id/eprint/26464

Actions (login required)

View Item View Item